TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · major macro event coming up
NVAX

Novavax Inc

Healthcare · Biotechnology

10.80$ +4.0% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Income Statement

Novavax Inc (NVAX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 1,123 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement NVAX
Line item 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
0.1 0.5 0.7 1.2 2.5 24 15 12 8.3 7.4 4.7 1.5 1.1 0.3 0.3 15 22 21 31 36 15 31 34 19 476 1,146 1,599 556 682 1,123
-0.3 -0.3 -0.3 -0.4 -0.6 4.1 3.6 2.1 3.5 5.8 6.5 0.2 34 37 37 7.0 15 8.2 15 163 238 168 174 114 747 13 903 344 203 71
0.4 0.8 1.0 1.6 3.1 20 11 9.7 4.8 1.6 -1.8 1.3 1.1 0.3 0.3 7.7 7.4 13 16 -126 -223 31 34 -95 476 1,146 696 213 479 1,052
3.7 2.9 3.4 3.4 9.4 11 12 10 7.4 5.1 12 18 24 26 28 18 26 50 79 163 238 168 174 114 747 2,535 1,235 738 391 337
1.9 2.4 2.5 2.4 5.9 18 22 16 33 17 11 14 11 12 11 11 11 15 20 31 47 34 34 34 145 298 489 475 337 157
5.9 5.6 6.2 6.2 16 29 33 26 29 11 23 32 35 38 39 29 37 65 99 193 284 203 208 148 892 2,833 1,341 779 728 489
-5.5 -4.8 -5.2 -4.6 -13 -9.3 -22 -16 -24 -9.2 -25 -30 -34 -37 -38 -22 -30 -52 -84 -157 -269 -172 -174 -121 -417 -1,687 -645 -567 -249 563
0.0 0.0 0.0 0.0 0.0 0.5 1.1 1.2 1.5 2.0 1.5 1.6 1.7 0.5 0.0 0.0 0.0 0.2 0.2 0.2 13 14 12 14 15 21 20 14 20 23
-5.4 -4.6 -4.9 -9.7 -23 -17 -26 -11 -23 -35 -36 -38 -36 -19 -29 -52 -83 -157 -280 -184 -185 -133 -418 -1,715 -654 -543 -177 442
0.1 -0.3 -0.4 -0.1 -0.6 1.5 2.0 -0.7 1.7 -0.2 -0.5 0.4 0.1 0.0 -5.2 -6.4 2.3 2.3 1.4 -2.6 9.2 29 4.3 2.0 11 1.9
-5.5 -4.5 -4.8 -4.5 -12 -9.7 -23 -17 -26 -11 -23 -35 -36 -38 -36 -19 -29 -52 -83 -157 -280 -184 -185 -130 -428 -1,744 -658 -545 -187 440
-5.2 -4.5 -4.9 -4.2 -12 -5.8 -20 -15 -21 -5.4 -18 -31 -34 -38 -36 -17 -27 -49 -78 -151 -261 -162 -166 -113 -412 -1,674 -605 -487 -108 492

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?